Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1335992
PUBLISHER: KBV Research | PRODUCT CODE: 1335992
Asia Pacific API Intermediate Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Application, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Asia Pacific API Intermediate Market would witness market growth of 7.6% CAGR during the forecast period (2023-2030).
The increasing frequency of different diseases is one of the key factors driving the market. The most frequently prescribed synthetic medications are used to treat diabetes and hypertension. It significantly contributes to the disease burden in developed and developing countries as a risk factor for ischemic heart disease and stroke.
The indications above are significant risk factors for other diseases and syndromes, including ischaemic heart disease, glaucoma, and cancer. Pharmaceuticals that have been artificially created, such as metformin, atorvastatin, and enalapril, are frequently prescribed to treat the indications mentioned above. The rising prevalence of various diseases, including illnesses with a variety of etiologies, is therefore anticipated to fuel demand for pharmaceutical drugs for disease management, which in turn is expected to contribute to the demand for APIs, positively affecting the expansion of the market throughout the forecast period.
According to the International Diabetes Federation, more than 60% of those who have diabetes reside in Asia, with nearly half of them in China and India combined. According to WHO, China has one of the world's fastest-rising aging populations. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. The prevalence of diseases like diabetes, cancer, and others is anticipated to rise along with the aging population as they are predicted to be more susceptible to developing a variety of ailments. The market participants operating in the regional nations are expected to have significant growth opportunities due to all these factors.
The China market dominated the Asia Pacific API Intermediate Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $23.7 billion by 2030. The Japan market is anticipated to grow at a CAGR of 6.9% during (2023 - 2030). Additionally, The India market would register a CAGR of 8.3% during (2023 - 2030).
Based on Type, the market is segmented into Bulk Drug Intermediates, and Chemical Intermediates. Based on End User, the market is segmented into Biotech & Pharmaceutical Companies, CMO, and Others. Based on Application, the market is segmented into Analgesics, Antidiabetic Drugs, Anti-Infective Drugs, Cardiovascular Drugs, Anticancer Drugs, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cation Pharma, Espee Group, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Cipla Limited, Cambrex Corporation, Vertellus, Dr. Reddy's Laboratories Ltd., Evonik Industries AG (RAG-Stiftung), Pfizer, Inc., Shree Ganesh Remedies Limited
Scope of the Study
Market Segments covered in the Report:
By Type
- Bulk Drug Intermediates
- Chemical Intermediates
By End User
- Biotech & Pharmaceutical Companies
- CMO
- Others
By Application
- Analgesics
- Antidiabetic Drugs
- Anti-Infective Drugs
- Cardiovascular Drugs
- Anticancer Drugs
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Cation Pharma
- Espee Group
- Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- Cipla Limited
- Cambrex Corporation
- Vertellus
- Dr. Reddy's Laboratories Ltd.
- Evonik Industries AG (RAG-Stiftung)
- Pfizer, Inc.
- Shree Ganesh Remedies Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific API Intermediate Market, by Type
- 1.4.2 Asia Pacific API Intermediate Market, by End User
- 1.4.3 Asia Pacific API Intermediate Market, by Application
- 1.4.4 Asia Pacific API Intermediate Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. Strategies Deployed in API Intermediate Market
Chapter 5. Asia Pacific API Intermediate Market by Type
- 5.1 Asia Pacific Bulk Drug Intermediates Market by Country
- 5.2 Asia Pacific Chemical Intermediates Market by Country
Chapter 6. Asia Pacific API Intermediate Market by End User
- 6.1 Asia Pacific Biotech & Pharmaceutical Companies Market by Country
- 6.2 Asia Pacific CMO Market by Country
- 6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific API Intermediate Market by Application
- 7.1 Asia Pacific Analgesics Market by Country
- 7.2 Asia Pacific Antidiabetic Drugs Market by Country
- 7.3 Asia Pacific Anti-Infective Drugs Market by Country
- 7.4 Asia Pacific Cardiovascular Drugs Market by Country
- 7.5 Asia Pacific Anticancer Drugs Market by Country
- 7.6 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific API Intermediate Market by Country
- 8.1 China API Intermediate Market
- 8.1.1 China API Intermediate Market by Type
- 8.1.2 China API Intermediate Market by End User
- 8.1.3 China API Intermediate Market by Application
- 8.2 Japan API Intermediate Market
- 8.2.1 Japan API Intermediate Market by Type
- 8.2.2 Japan API Intermediate Market by End User
- 8.2.3 Japan API Intermediate Market by Application
- 8.3 India API Intermediate Market
- 8.3.1 India API Intermediate Market by Type
- 8.3.2 India API Intermediate Market by End User
- 8.3.3 India API Intermediate Market by Application
- 8.4 South Korea API Intermediate Market
- 8.4.1 South Korea API Intermediate Market by Type
- 8.4.2 South Korea API Intermediate Market by End User
- 8.4.3 South Korea API Intermediate Market by Application
- 8.5 Singapore API Intermediate Market
- 8.5.1 Singapore API Intermediate Market by Type
- 8.5.2 Singapore API Intermediate Market by End User
- 8.5.3 Singapore API Intermediate Market by Application
- 8.6 Malaysia API Intermediate Market
- 8.6.1 Malaysia API Intermediate Market by Type
- 8.6.2 Malaysia API Intermediate Market by End User
- 8.6.3 Malaysia API Intermediate Market by Application
- 8.7 Rest of Asia Pacific API Intermediate Market
- 8.7.1 Rest of Asia Pacific API Intermediate Market by Type
- 8.7.2 Rest of Asia Pacific API Intermediate Market by End User
- 8.7.3 Rest of Asia Pacific API Intermediate Market by Application
Chapter 9. Company Profiles
- 9.1 Cation Pharma
- 9.1.1 Company Overview
- 9.1.2 SWOT Analysis
- 9.2 Espee Group
- 9.2.1 Company Overview
- 9.2.2 Recent strategies and developments:
- 9.2.2.1 Trials and Approvals:
- 9.3 Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- 9.3.1 Company Overview
- 9.3.2 SWOT Analysis
- 9.4 Cipla Limited
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
- 9.5 Cambrex Corporation
- 9.5.1 Company Overview
- 9.5.2 Recent strategies and developments:
- 9.5.2.1 Acquisition and Mergers:
- 9.5.3 SWOT Analysis
- 9.6 Vertellus
- 9.6.1 Company Overview
- 9.6.2 SWOT Analysis
- 9.7 Dr. Reddy's Laboratories Ltd.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.6 SWOT Analysis
- 9.8 Evonik Industries AG (RAG-Stiftung)
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Partnerships, Collaborations, and Agreements:
- 9.8.5.2 Geographical Expansions:
- 9.8.6 SWOT Analysis
- 9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional & Segmental Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Geographical Expansions:
- 9.9.6 SWOT Analysis
- 9.10. SHREE GANESH REMEDIES LIMITED
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 SWOT Analysis
LIST OF TABLES
- TABLE 1 Asia Pacific API Intermediate Market, 2019 - 2022, USD Million
- TABLE 2 Asia Pacific API Intermediate Market, 2023 - 2030, USD Million
- TABLE 3 Asia Pacific API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 4 Asia Pacific API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 5 Asia Pacific Bulk Drug Intermediates Market by Country, 2019 - 2022, USD Million
- TABLE 6 Asia Pacific Bulk Drug Intermediates Market by Country, 2023 - 2030, USD Million
- TABLE 7 Asia Pacific Chemical Intermediates Market by Country, 2019 - 2022, USD Million
- TABLE 8 Asia Pacific Chemical Intermediates Market by Country, 2023 - 2030, USD Million
- TABLE 9 Asia Pacific API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 10 Asia Pacific API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 11 Asia Pacific Biotech & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Million
- TABLE 12 Asia Pacific Biotech & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Million
- TABLE 13 Asia Pacific CMO Market by Country, 2019 - 2022, USD Million
- TABLE 14 Asia Pacific CMO Market by Country, 2023 - 2030, USD Million
- TABLE 15 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 16 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 17 Asia Pacific API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 18 Asia Pacific API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 19 Asia Pacific Analgesics Market by Country, 2019 - 2022, USD Million
- TABLE 20 Asia Pacific Analgesics Market by Country, 2023 - 2030, USD Million
- TABLE 21 Asia Pacific Antidiabetic Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 22 Asia Pacific Antidiabetic Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 23 Asia Pacific Anti-Infective Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 24 Asia Pacific Anti-Infective Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 25 Asia Pacific Cardiovascular Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 26 Asia Pacific Cardiovascular Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 27 Asia Pacific Anticancer Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 28 Asia Pacific Anticancer Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 29 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 30 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 31 Asia Pacific API Intermediate Market by Country, 2019 - 2022, USD Million
- TABLE 32 Asia Pacific API Intermediate Market by Country, 2023 - 2030, USD Million
- TABLE 33 China API Intermediate Market, 2019 - 2022, USD Million
- TABLE 34 China API Intermediate Market, 2023 - 2030, USD Million
- TABLE 35 China API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 36 China API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 37 China API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 38 China API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 39 China API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 40 China API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 41 Japan API Intermediate Market, 2019 - 2022, USD Million
- TABLE 42 Japan API Intermediate Market, 2023 - 2030, USD Million
- TABLE 43 Japan API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 44 Japan API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 45 Japan API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 46 Japan API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 47 Japan API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 48 Japan API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 49 India API Intermediate Market, 2019 - 2022, USD Million
- TABLE 50 India API Intermediate Market, 2023 - 2030, USD Million
- TABLE 51 India API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 52 India API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 53 India API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 54 India API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 55 India API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 56 India API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 57 South Korea API Intermediate Market, 2019 - 2022, USD Million
- TABLE 58 South Korea API Intermediate Market, 2023 - 2030, USD Million
- TABLE 59 South Korea API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 60 South Korea API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 61 South Korea API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 62 South Korea API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 63 South Korea API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 64 South Korea API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 65 Singapore API Intermediate Market, 2019 - 2022, USD Million
- TABLE 66 Singapore API Intermediate Market, 2023 - 2030, USD Million
- TABLE 67 Singapore API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 68 Singapore API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 69 Singapore API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 70 Singapore API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 71 Singapore API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 72 Singapore API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 73 Malaysia API Intermediate Market, 2019 - 2022, USD Million
- TABLE 74 Malaysia API Intermediate Market, 2023 - 2030, USD Million
- TABLE 75 Malaysia API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 76 Malaysia API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 77 Malaysia API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 78 Malaysia API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 79 Malaysia API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 80 Malaysia API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 81 Rest of Asia Pacific API Intermediate Market, 2019 - 2022, USD Million
- TABLE 82 Rest of Asia Pacific API Intermediate Market, 2023 - 2030, USD Million
- TABLE 83 Rest of Asia Pacific API Intermediate Market by Type, 2019 - 2022, USD Million
- TABLE 84 Rest of Asia Pacific API Intermediate Market by Type, 2023 - 2030, USD Million
- TABLE 85 Rest of Asia Pacific API Intermediate Market by End User, 2019 - 2022, USD Million
- TABLE 86 Rest of Asia Pacific API Intermediate Market by End User, 2023 - 2030, USD Million
- TABLE 87 Rest of Asia Pacific API Intermediate Market by Application, 2019 - 2022, USD Million
- TABLE 88 Rest of Asia Pacific API Intermediate Market by Application, 2023 - 2030, USD Million
- TABLE 89 Key Information - Cation Pharma
- TABLE 90 Key Information - Espee Group
- TABLE 91 Key Information - Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- TABLE 92 Key Information - Cipla Limited
- TABLE 93 Key Information - Cambrex Corporation
- TABLE 94 Key Information - Vertellus
- TABLE 95 key information - Dr. Reddy's Laboratories Ltd.
- TABLE 96 Key Information - Evonik Industries AG
- TABLE 97 Key Information - Pfizer, Inc.
- TABLE 98 Key Information - SHREE GANESH REMEDIES LIMITED
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Asia Pacific API Intermediate Market, 2019 - 2030, USD Million
- FIG 3 Key Impacting Factors API intermediate market
- FIG 4 Porter's Five Forces Analysis - API Intermediate Market
- FIG 5 Asia Pacific API Intermediate Market share by Type, 2022
- FIG 6 Asia Pacific API Intermediate Market share by Type, 2030
- FIG 7 Asia Pacific API Intermediate Market by Type, 2019 - 2030, USD Million
- FIG 8 Asia Pacific API Intermediate Market share by End User, 2022
- FIG 9 Asia Pacific API Intermediate Market share by End User, 2030
- FIG 10 Asia Pacific API Intermediate Market by End User, 2019 - 2030, USD Million
- FIG 11 Asia Pacific API Intermediate Market share by Application, 2022
- FIG 12 Asia Pacific API Intermediate Market share by Application, 2030
- FIG 13 Asia Pacific API Intermediate Market by Application, 2019 - 2030, USD Million
- FIG 14 Asia Pacific API Intermediate Market share by Country, 2022
- FIG 15 Asia Pacific API Intermediate Market share by Country, 2030
- FIG 16 Asia Pacific API Intermediate Market by Country, 2019 - 2030, USD Million
- FIG 17 Swot Analysis: Cation Pharma
- FIG 18 Swot Analysis: Sandoo Pharmaceuticals and Chemicals Co., Ltd.
- FIG 19 SWOT Analysis: Cipla Limited
- FIG 20 Swot Analysis: Cambrex Corporation
- FIG 21 Swot Analysis: Vertellus
- FIG 22 Swot Analysis: Dr. Reddy's Laboratories Ltd.
- FIG 23 Recent strategies and developments: Evonik Industries AG
- FIG 24 Swot Analysis: Evonik Industries AG
- FIG 25 Swot Analysis: Pfizer, Inc.
- FIG 26 Swot Analysis: SHREE GANESH REMEDIES LIMITED
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.